Search research articles
Contact Us
Filters
Showing results (101-110 of 186) with videos related to
Page
of 19
Sort By:
Nature
|
February 14, 2019
Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers
David M Hyman, Sarina A Piha-Paul, Helen Won, et al.
Nature
|
February 9, 2018
HER kinase inhibition in patients with HER2- and HER3-mutant cancers
David M Hyman, Sarina A Piha-Paul, Helen Won, et al.
Cancer Discovery
|
December 7, 2019
Efficacy and Determinants of Response to HER Kinase Inhibition in <i>HER2</i>-Mutant Metastatic Breast Cancer
Lillian M Smyth, Sarina A Piha-Paul, Helen H Won, et al.
Cancer Discovery
|
November 2, 2023
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia
Andreas Varkaris, Ermira Pazolli, Hakan Gunaydin, et al.
Blood
|
August 18, 2023
BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis
Aldo A Acosta-Medina, Paul G Kemps, Timo C E Zondag, et al.
Physical Review Letters
|
September 22, 2023
Tritium Beta Spectrum Measurement and Neutrino Mass Limit from Cyclotron Radiation Emission Spectroscopy
A Ashtari Esfahani, S Böser, N Buzinsky, et al.
Nature Medicine
|
May 9, 2017
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir, Ryma Benayed, Ronak H Shah, et al.
Nature Medicine
|
August 5, 2017
Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir, Ryma Benayed, Ronak H Shah, et al.
Physical Review Letters
|
December 21, 2011
Search for hadronic decays of a light Higgs boson in the radiative decay Υ→γA0
J P Lees, V Poireau, V Tisserand, et al.
Physical Review Letters
|
September 26, 2012
Search for low-mass dark-sector Higgs bosons
J P Lees, V Poireau, V Tisserand, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 186) with videos related to
Sort By:
Page
of 19
Nature
|
February 14, 2019
Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers
David M Hyman, Sarina A Piha-Paul, Helen Won, et al.
Nature
|
February 9, 2018
HER kinase inhibition in patients with HER2- and HER3-mutant cancers
David M Hyman, Sarina A Piha-Paul, Helen Won, et al.
Cancer Discovery
|
December 7, 2019
Efficacy and Determinants of Response to HER Kinase Inhibition in <i>HER2</i>-Mutant Metastatic Breast Cancer
Lillian M Smyth, Sarina A Piha-Paul, Helen H Won, et al.
Cancer Discovery
|
November 2, 2023
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia
Andreas Varkaris, Ermira Pazolli, Hakan Gunaydin, et al.
Blood
|
August 18, 2023
BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis
Aldo A Acosta-Medina, Paul G Kemps, Timo C E Zondag, et al.
Physical Review Letters
|
September 22, 2023
Tritium Beta Spectrum Measurement and Neutrino Mass Limit from Cyclotron Radiation Emission Spectroscopy
A Ashtari Esfahani, S Böser, N Buzinsky, et al.
Nature Medicine
|
May 9, 2017
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir, Ryma Benayed, Ronak H Shah, et al.
Nature Medicine
|
August 5, 2017
Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir, Ryma Benayed, Ronak H Shah, et al.
Physical Review Letters
|
December 21, 2011
Search for hadronic decays of a light Higgs boson in the radiative decay Υ→γA0
J P Lees, V Poireau, V Tisserand, et al.
Physical Review Letters
|
September 26, 2012
Search for low-mass dark-sector Higgs bosons
J P Lees, V Poireau, V Tisserand, et al.
Page
of 19